Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill would move marijuana from Schedule I to Schedule III of the Controlled Substances Act, reducing its federal classification as a dangerous drug with no medical use to one with accepted medical applications and lower abuse potential. The change would affect marijuana users, medical researchers, healthcare providers, and the pharmaceutical industry by potentially allowing greater research access and opening pathways for medical use. The Attorney General must complete the rescheduling within 60 days of the bill becoming law. The legislation does not involve direct federal spending but would significantly impact how marijuana is regulated and researched at the federal level. The bill was introduced in August 2025 and referred to the House Energy and Commerce and Judiciary Committees.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.